|
JPH0747045B2
(ja)
|
1986-10-15 |
1995-05-24 |
株式会社大協精工 |
積層した注射器用滑栓
|
|
JP3100727B2
(ja)
|
1992-01-23 |
2000-10-23 |
株式会社大協精工 |
変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品
|
|
JP3172057B2
(ja)
|
1995-04-05 |
2001-06-04 |
株式会社大協精工 |
ラミネートゴム栓
|
|
US20020035058A1
(en)
|
1996-05-15 |
2002-03-21 |
The University Of Sheffield |
Isopentenyl pyrophosphate isomerase (IPI) and/or prenyl transferase inhibitors
|
|
US6030831A
(en)
|
1997-09-19 |
2000-02-29 |
Genetech, Inc. |
Tie ligand homologues
|
|
US6172071B1
(en)
|
1998-07-30 |
2001-01-09 |
Hughes Institute |
Lipid-lowering quinazoline derivative
|
|
JP3512349B2
(ja)
|
1999-01-29 |
2004-03-29 |
株式会社大協精工 |
柱状ゴム要素の成形型
|
|
AU781295B2
(en)
|
1999-02-12 |
2005-05-12 |
President And Fellows Of Harvard College |
Inhibiting formation of atherosclerotic lesions
|
|
US6629949B1
(en)
|
2000-05-08 |
2003-10-07 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
US6659982B2
(en)
|
2000-05-08 |
2003-12-09 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
JP2002209975A
(ja)
|
2001-01-19 |
2002-07-30 |
Daikyo Seiko Ltd |
医薬バイアル用ラミネートゴム栓
|
|
NZ527408A
(en)
|
2001-02-22 |
2005-04-29 |
Skyepharma Canada Inc |
Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
|
|
JP5105696B2
(ja)
|
2001-11-16 |
2012-12-26 |
ジェネンテック， インコーポレイテッド |
アンジオポエチン様タンパク質３Ａｎｇｐｔｌ３含有組成物とその使用方法
|
|
US20070185017A1
(en)
|
2002-10-29 |
2007-08-09 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
JP2005080508A
(ja)
|
2003-09-04 |
2005-03-31 |
Sankyo Co Ltd |
脂質代謝改善剤の試験方法
|
|
AU2006223579A1
(en)
|
2005-03-11 |
2006-09-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
PL2121751T3
(pl)
|
2006-12-08 |
2017-07-31 |
Lexicon Pharmaceuticals, Inc. |
Przeciwciała monoklonalne przeciwko ANGPTL3
|
|
AR070315A1
(es)
*
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
|
EP2216016A1
(en)
|
2009-02-06 |
2010-08-11 |
LEK Pharmaceuticals d.d. |
Process for the preparation of a pharmaceutical composition comprising ezetimibe
|
|
JP5711671B2
(ja)
|
2009-02-23 |
2015-05-07 |
ナノルクス、インコーポレイテッドＮａｎｏｒｘ，Ｉｎｃ． |
ポリコサノールナノ粒子
|
|
CN101852805B
(zh)
|
2009-03-31 |
2015-04-01 |
浙江大学 |
Angptl3作为卵巢癌的诊断标记物的用途
|
|
AU2010273570B2
(en)
|
2009-07-14 |
2014-07-03 |
Novartis Ag |
Mesenchymal stem cell differentiation
|
|
US8653047B2
(en)
|
2010-01-08 |
2014-02-18 |
Isis Pharmaceuticals, Inc. |
Modulation of angiopoietin-like 3 expression
|
|
AR087329A1
(es)
|
2011-06-17 |
2014-03-19 |
Regeneron Pharma |
Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
|
|
ES2923573T3
(es)
|
2011-06-21 |
2022-09-28 |
Alnylam Pharmaceuticals Inc |
Composiciones de ARNi de proteína 3 de tipo angiopoyetina (ANGPTL3) y métodos de uso de las mismas
|
|
US9574005B2
(en)
|
2011-07-19 |
2017-02-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stable Protein-containing preparation containing argininamide or analogous compound thereof
|
|
US20150239970A1
(en)
|
2012-10-25 |
2015-08-27 |
Medimmune, Llc |
Stable, Low Viscosity Antibody Formulation
|
|
EP2996706B1
(en)
|
2013-03-14 |
2019-07-31 |
UAB Research Foundation |
Apolipoprotein mimetics and uses thereof
|
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
|
TW202021614A
(zh)
|
2013-06-07 |
2020-06-16 |
法商賽諾菲生物技術公司 |
藉由投與ｐｃｓｋ９抑制劑抑制動脈粥狀硬化的方法
|
|
HK1224186A1
(zh)
|
2013-11-20 |
2017-08-18 |
Cymabay Therapeutics, Inc. |
纯阖家族型高胆固醇血症的治疗
|
|
CN111394355A
(zh)
|
2013-12-24 |
2020-07-10 |
Ionis制药公司 |
促血管生成素样3表达的调节
|
|
PT3137605T
(pt)
|
2014-05-01 |
2020-12-18 |
Ionis Pharmaceuticals Inc |
Composições e métodos para modulação da expressão de angiopoietina de tipo 3
|
|
RU2723018C2
(ru)
|
2014-07-16 |
2020-06-08 |
Санофи Байотекнолоджи |
Способы лечения пациентов с высоким риском возникновения сердечно-сосудистых заболеваний, имеющих гиперхолестеринемию
|
|
PL3169353T3
(pl)
|
2014-07-16 |
2020-06-01 |
Sanofi Biotechnology |
SPOSOBY LECZENIA PACJENTÓW Z HETEROZYGOTYCZNĄ HIPERCHOLESTEROLEMIĄ RODZINNĄ (heFH)
|
|
EP3822287A1
(en)
|
2014-10-03 |
2021-05-19 |
NGM Biopharmaceuticals, Inc. |
Angptl8 polypeptide and its use for treatment of conditions associated with elevated triglycerides
|
|
TW201713690A
(zh)
|
2015-08-07 |
2017-04-16 |
再生元醫藥公司 |
抗ａｎｇｐｔｌ８抗體及其用途
|
|
PL3416684T3
(pl)
|
2016-02-17 |
2023-11-06 |
Regeneron Pharmaceuticals, Inc. |
Sposoby leczenia lub profilaktyki miażdżycy tętnic przez podawanie inhibitora angptl3
|
|
JP7541810B2
(ja)
|
2016-03-03 |
2024-08-29 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ａｎｇｐｔｌ３阻害剤と組み合わせてｐｃｓｋ９阻害剤を投与することにより高脂血症を有する患者を処置するための方法
|
|
KR20180132843A
(ko)
|
2016-04-08 |
2018-12-12 |
리제너론 파아마슈티컬스, 인크. |
Angptl8 억제제 및 angptl3 억제제로 고지혈증을 치료하는 방법
|
|
IL293308B2
(en)
|
2016-04-28 |
2024-12-01 |
Regeneron Pharma |
Methods for treating patients with familial hypercholesterolemia
|
|
US11603407B2
(en)
|
2017-04-06 |
2023-03-14 |
Regeneron Pharmaceuticals, Inc. |
Stable antibody formulation
|
|
AU2021320417A1
(en)
|
2020-08-07 |
2023-03-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating refractory hypercholesterolemia involving an ANGPTL3 inhibitor
|